The association of high DSCAM-AS1 levels with poor overall survival (OS) we observed after in silico analysis of open-source data of 543 endometrial cancer patients is in line with similar findings in breast cancer, melanoma, non-small cell lung cancer, colon cancer and osteosarcoma [15,18,19,21,23,47]. Here, DSCAM is linked to breast carcinoma.